CN Patent

CN110244053B — 用于诊断狼疮肾炎并肺动脉高压疾病的分子标志物及其用途

Assigned to Peking University Third Hospital Peking University Third Clinical Medical College · Expires 2022-03-11 · 4y expired

What this patent protects

本发明的目的是提供用于诊断狼疮肾炎并肺动脉高压疾病的分子标志物及其用途，利用补体因子H、补体Bb片段作为诊断或预测狼疮肾炎并肺动脉高压疾病的分子标志物能够简便、准确的诊断或预测狼疮肾炎患者是否合并肺动脉高压或其发病风险。相较于右心导管检查等侵入性检查手段，更加适合临床推广。

USPTO Abstract

本发明的目的是提供用于诊断狼疮肾炎并肺动脉高压疾病的分子标志物及其用途，利用补体因子H、补体Bb片段作为诊断或预测狼疮肾炎并肺动脉高压疾病的分子标志物能够简便、准确的诊断或预测狼疮肾炎患者是否合并肺动脉高压或其发病风险。相较于右心导管检查等侵入性检查手段，更加适合临床推广。

Drugs covered by this patent

Patent Metadata

Patent number: CN110244053B
Jurisdiction: CN
Classification: —
Expires: 2022-03-11
Drug substance claim: No
Drug product claim: No
Assignee: Peking University Third Hospital Peking University Third Clinical Medical College
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.